Literature DB >> 10414600

Serum antibodies anti-H. pylori and anti-CagA: a comparison between four different assays.

D Basso1, A Stefani, L Brigato, F Navaglia, E Greco, C F Zambon, M G Piva, A Toma, F Di Mario, M Plebani.   

Abstract

The authors compare efficacy of two ELISA assays (one supplied by DIAMEDIX [Delta Biological s.r.l.], and the other by RADIM [RADIM I]) in detecting total anti-H. pylori antibodies, and of two further ELISA methods (one supplied by EUROSPITAL [Helori CTX IgG] and the other by RADIM [RADIM 2]) in identifying anti-CagA antibodies, using sera from 69 controls (20 adults and 49 children) and from 96 patients, obtained before endoscopy. Seventy-three of the patients had H. pylori infection, while the remaining 23 were H. pylori negative (histology and polymerase chain reaction [PCR]). Fifty-two of the H. pylori positive patients, had cagA-positive strain infection, identified by PCR. The DIAMEDIX assay was found to be more sensitive (92%) than RADIM 1 (79%) in identifying H. pylori positive patients, irrespective of the infecting strain. On the other hand, the DIAMEDIX assay was less specific than RADIM 1 for H. pylori-negative patients (43% vs. 83%). However, when patients already treated for H. pylori infection were excluded from the group of H. pylori-negative patients, the DIAMEDIX assay had a specificity of 89%. In identifying anti-CagA antibodies, the kit supplied by RADIM (RADIM 2) had a sensitivity of 90% and a specificity of 94%, whereas that supplied by EUROSPITAL had a sensitivity of 100% and a specificity of 76%. The performances of the two methods in the identification of anti-CagA antibodies were found to be similar. The authors conclude that, in view of its high sensitivity, the DIAMEDIX assay may be useful in screening for H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414600      PMCID: PMC6807944          DOI: 10.1002/(sici)1098-2825(1999)13:4<194::aid-jcla9>3.0.co;2-e

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

1.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Authors:  J Parsonnet; G D Friedman; N Orentreich; H Vogelman
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology.

Authors:  F Navaglia; D Basso; M G Piva; L Brigato; A Stefani; N Dal Bò; F Di Mario; M Rugge; M Plebani
Journal:  Am J Gastroenterol       Date:  1998-02       Impact factor: 10.864

3.  Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori.

Authors:  J C Atherton; R M Peek; K T Tham; T L Cover; M J Blaser
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

4.  Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection.

Authors:  D Basso; F Navaglia; M Cassaro; M Scrigner; A Toma; N Dal Bo; F Di Mario; M Rugge; M Plebani
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

5.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

6.  Serologic detection of infection with cagA+ Helicobacter pylori strains.

Authors:  T L Cover; Y Glupczynski; A P Lage; A Burette; M K Tummuru; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

7.  Helicobacter pylori serology in patients with chronic gastritis.

Authors:  M Plebani; D Basso; M Cassaro; L Brigato; M Scrigner; A Toma; F Di Mario; M Rugge
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

8.  Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection.

Authors:  N Figura
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

9.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration.

Authors:  J C Atherton; P Cao; R M Peek; M K Tummuru; M J Blaser; T L Cover
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

View more
  7 in total

1.  Relation of CagA seropositivity to cagPAI phenotype and histological grade of gastritis in patients with Helicobacter pylori infection.

Authors:  Tadashi Shimoyama; Shinsaku Fukuda; Fumika Nakasato; Tetsuro Yoshimura; Tatsuya Mikami; Akihiro Munakata
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  Risk factor analysis for metaplastic gastritis in Koreans.

Authors:  Soonami Choi; Yun Jeong Lim; Sue Kyung Park
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.

Authors:  C Sostres; P Carrera-Lasfuentes; R Benito; P Roncales; M Arruebo; M T Arroyo; L Bujanda; L A García-Rodríguez; A Lanas
Journal:  Am J Gastroenterol       Date:  2015-04-21       Impact factor: 10.864

4.  Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries.

Authors:  Seiji Shiota; Osamu Matsunari; Masahide Watada; Yoshio Yamaoka
Journal:  Future Microbiol       Date:  2010-12       Impact factor: 3.165

5.  Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response.

Authors:  C Figueiredo; W Quint; N Nouhan; H van den Munckhof; P Herbrink; J Scherpenisse; W de Boer; P Schneeberger; G Perez-Perez; M J Blaser; L J van Doorn
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Accuracy of a commercial enzyme-linked immunosorbent assay for CagA in patients from Brazil with and without gastric carcinoma.

Authors:  Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Adriana Santos; Celso Affonso de Oliveira; Dulciene Maria Magalhães Queiroz
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 7.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.